ScholarLens Back to search
2006•Journal of Pediatric PharmacyRequires access

The treatment of cough variant asthma with montelukast

Hua Gao

Open publisher page 0 citations

Abstract

Objective:To observe the effect of montelukast on the cough variant asthma(CVA). Methods: 78 cases of CVA were randomly divided into two groups.The control group received not only conventional treatments such as terbutaline and ketotifen.The treatment group received not only conventional ones but also montelukast.The treatment was kept for other 12 weeks after the clinical symptoms disappeared.The same follow-up was done. Results: The remission time of the treatment group was shorter than that of the control group(P0.01),and the recurrence rate was lower(P0.01). Conclusions: The treatment of cough variant asthma with montelukast was significant and adverse reaction was low.

About this research paper

What this paper is about

Objective:To observe the effect of montelukast on the cough variant asthma(CVA). Methods: 78 cases of CVA were randomly divided into two groups.The control group received not only conventional treatments such as terbutaline and ketotifen.The treatment group received not only conventional ones but also montelukast.The treatment was kept for other 12 weeks after the clinical symptoms disappeared.The same follow-up was done. Results: The remission time of the treatment group was shorter than that of the control group(P0.01),and the recurrence rate was lower(P0.01). Conclusions: The treatment of cough variant asthma with montelukast was significant and adverse reaction was low.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective:To observe the effect of montelukast on the cough variant asthma(CVA). Methods: 78 cases of CVA were randomly divided into two groups.The control group received not only conventional treatments such as terbutaline and ketotifen.The treatment group received not only conventional ones but also montelukast.The treatment was kept for other 12 weeks after the clinical symptoms disappeared.The same follow-up was done. Results: The remission time of the treatment group was shorter than that of the control group(P0.01),and the recurrence rate was lower(P0.01). Conclusions: The treatment of cough variant asthma with montelukast was significant and adverse reaction was low.

Key concepts: Montelukast, Medicine, Terbutaline, Ketotifen, Asthma, Anesthesia, Adverse effect, Internal medicine

Related papers

Related paper 1Related paper 2Related paper 3
Back to paper searchBrowse research topicsOriginal source
The treatment of cough variant asthma with montelukast — Research Paper | ScholarLens